메뉴 건너뛰기




Volumn 55, Issue 3, 2005, Pages 396-398

In vitro activity of ertapenem against bacteraemic pneumococci: Report of a French multicentre study including 339 strains [2]

(99)  Decousser, Jean Winoc a,b   Methlouthi, Imen a   Pina, Patrick c   Allouch, Pierre a   Auvray, C d   Bailly, A d   Barrans, A d   Barraud, D d   Benoit, C d   Bichier, E d   Biessy, H d   Bietrix, M d   Bineau, P d   Blanc, V d   Bland, S d   Boisivon, A d   Boucand Maitre, Y d   Bouguigny Saison, C d   Brisou, P d   Brovedani, S d   more..

d NONE

Author keywords

Bacteraemia; Carbapenems; France; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; DALFOPRISTIN PLUS QUINUPRISTIN; ERTAPENEM; ERYTHROMYCIN; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; PENICILLIN G;

EID: 20144370018     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki019     Document Type: Letter
Times cited : (3)

References (6)
  • 1
    • 15844421200 scopus 로고    scopus 로고
    • European Antimicrobial Resistance Surveillance System. EARSS Annual Report 2002. [Online.] (25 October 2004, date last accessed)
    • European Antimicrobial Resistance Surveillance System. (2003). EARSS Annual Report 2002. [Online.] http://www.earss.rivm.nl/index.html (25 October 2004, date last accessed).
    • (2003)
  • 2
    • 0345550450 scopus 로고    scopus 로고
    • Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults
    • Mandell, L. A., Bartlett, J. G., Dowell, S. F. et al. (2003). Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clinical Infectious Diseases 37, 1405-33.
    • (2003) Clinical Infectious Diseases , vol.37 , pp. 1405-1433
    • Mandell, L.A.1    Bartlett, J.G.2    Dowell, S.F.3
  • 4
    • 8844269107 scopus 로고    scopus 로고
    • In vitro activity of ertapenem against selected respiratory pathogens
    • Marchese, A., Gualco, L., Schito, A. M. et al. (2004). In vitro activity of ertapenem against selected respiratory pathogens. Journal of Antimicrobial Chemotherapy 54, 944-51.
    • (2004) Journal of Antimicrobial Chemotherapy , vol.54 , pp. 944-951
    • Marchese, A.1    Gualco, L.2    Schito, A.M.3
  • 5
    • 2442657715 scopus 로고    scopus 로고
    • 'Collateral damage' from cephalosporin or quinolone antibiotic therapy
    • Paterson, D. L. (2004). 'Collateral damage' from cephalosporin or quinolone antibiotic therapy. Clinical Infectious Diseases 38, Suppl. 4, S341-5.
    • (2004) Clinical Infectious Diseases , vol.38 , Issue.SUPPL. 4
    • Paterson, D.L.1
  • 6
    • 2442702754 scopus 로고    scopus 로고
    • Quinolone resistance among pneumococci: Therapeutic and diagnostic implications
    • Low, D. E. (2004). Quinolone resistance among pneumococci: therapeutic and diagnostic implications. Clinical Infectious Diseases 38, Suppl. 4, S357-62.
    • (2004) Clinical Infectious Diseases , vol.38 , Issue.SUPPL. 4
    • Low, D.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.